Chemotherapy with BEACOPP may challenge ABVD as the standard of care for patients with Hodgkin's disease

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 6-6(1)

Publisher: Adis International

Keywords: Bleomycin, therapeutic use; Cyclophosphamide, therapeutic use; Dacarbazine, therapeutic use; Doxorubicin, therapeutic use; Etoposide, therapeutic use; Hodgkin's-disease, treatment; Prednisone, therapeutic use; Procarbazine, therapeutic use; Vinblastine, therapeutic use; Vincristine, therapeutic use

Document Type: Research article

Links for this article